Heart tests to measure risk in chronic heart failure
Part of Heart & circulation clinical trials.
This study uses simple heart tests and blood markers to sort people with chronic heart failure into different risk levels, which may help guide treatment. You may join if you have heart failure symptoms and certain test findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have been diagnosed with chronic heart failure by a doctor.
- You have typical symptoms like shortness of breath, fatigue, or swelling, plus a blood test showing elevated NT-proBNP (a heart stress marker).
- You have had an echocardiogram (ultrasound of the heart) showing some structural or functional abnormality, such as reduced pumping function or thickened heart walls.
- You are not on dialysis for kidney failure, and you do not have severe lung disease, active cancer, or other serious non-heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This trial tests a multidisciplinary care approach aimed at helping people with high risk for heart failure get diagnosed earlier. It may help you catch heart failure sooner if it starts, so treatment can begin earlier.
This trial studies how to better assess and manage risk in people hospitalized with heart failure or related serious heart problems. It may help by improving how clinicians monitor your condition over time and decide next steps.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
This study looks at how heart failure affects the heart, kidneys, liver, and metabolism, and may help find better ways to manage these related health issues.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.